Cargando…
Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells
BACKGROUND: Triple negative breast cancer is more aggressive than other breast cancer subtypes and constitutes a public health problem worldwide since it has high morbidity and mortality due to the lack of defined therapeutic targets. Resistance to chemotherapy complicates the course of patients’ tr...
Autores principales: | Español, Alejandro, Sanchez, Yamila, Salem, Agustina, Obregon, Jaqueline, Sales, Maria Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244968/ https://www.ncbi.nlm.nih.gov/pubmed/35949430 http://dx.doi.org/10.5306/wjco.v13.i6.505 |
Ejemplares similares
-
Breast cancer: Muscarinic receptors as new targets for tumor therapy
por: Español, Alejandro, et al.
Publicado: (2021) -
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M(2) receptor subtype
por: Español, Alejandro J., et al.
Publicado: (2020) -
Expression of nucleus accumbens-1 in colon cancer negatively modulates antitumor immunity
por: Shen, Zhao-Hua, et al.
Publicado: (2022) -
Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
por: Castaneda, Carlos A, et al.
Publicado: (2016) -
Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy
por: Sales, María E., et al.
Publicado: (2019)